Thursday, March 15, 2018

Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems

Recent work has developed solid drug nanoparticles (SDNs) of efavirenz that have been demonstrated, preclinically, improved oral bioavailability and the potential to enable up to a 50% dose reduction, and is c...

from Most Recent Articles: Journal of Nanobiotechnology http://ift.tt/2IqH1u0
via IFTTT

No comments:

Post a Comment